The latest RWE trends from top 50 pharma
On Tuesday, May 25, 2021 we hosted a workshop on “Using RWE to drive next-level commercial impact.” It was attended by 35 commercial, HEOR, and RWE experts, from over 25 different [...]
Clarify Health Launches Real-World Evidence on Health Disparities
Clarify Health launched new applications of its anonymized patient-level social determinants of health (SDoH) insights to help life sciences companies on their patient-first missions. With real-world evidence (RWE) software products, Clarify Growth and Clarify [...]
Surfacing hard-to-identify patients
The challenge of underdiagnoses when launching a rare disease drug There are 7,000 known rare diseases and 95 percent of them do not have any FDA-approved therapeutic. However, with greater [...]
Light up the patient journey with self-service analytics
In a full digitized future, biopharmaceutical companies should be able to process and analyze medical disparities and Real-World Evidence data to crystallize patient care journeys across any therapeutic areas - [...]
The analytics your BD&L team could be missing
Whether you’re sizing the addressable market for a specific disease area or refining your pricing assumptions for a potential new asset, you need analytics that can give you on-demand, precise inputs, fast. That [...]